This site use cookies

This site uses cookies that help us to improve our site by providing analytics and usage information. By clicking accept or continuing to use this site you are agreeing to our cookie policy. If you do not agree, please close this notice. Learn more

Latest updates

In the press

Exonate appoints Olav Hellebø as Chief Executive Officer

Latest updates

In the press, Company news

A day in the life of a Senior Scientist
In the press, Company news

Exonate Announces Collaboration with Janssen to develop a new eye drop for the treatment of retinal vascular diseases including wet age-related macular degeneration (AMD) and diabetic macular oedema (DMO)